Pedrosa Rui, Gomes Pedro, Soares-da-Silva Patricío
Institute of Pharmacology Therapeutics, Faculty of Medicine, Porto, Portugal.
Cell Physiol Biochem. 2004;14(1-2):91-100. doi: 10.1159/000076930.
Dopamine D1-like receptors are linked via G proteins to multiple cellular signaling pathways, namely adenylyl cyclase (AC) and phospholipase C (PLC). We have previously shown that the D1-mediated inhibition of Na+-K+-ATPase activity in OK cells involves the sequential activation of the AC-protein kinase A (AC-PKA) and the PLC-protein kinase C (PLC-PKC) pathways. The present study evaluated signaling cascades involved in dopamine-mediated inhibition of Na+/H+ exchanger isoform 3 (NHE3) in rat and opossum renal cells. Na+/H+ exchanger activity was assayed as the initial rate of intracellular pH (pHi) recovery after an acid load. Vmax values (in pH units/s) for Na+-dependent pHi recovery in rat cells (0.0097+/-0.0007) were greater (P<0.05) those in opossum cells (0.0063+/-0.0007), with similar Km values (in mM) for Na+ (rat, 35+/-9; opossum, 24+/-9). The IC50 values for EIPA and amiloride induced decrease in NHE activity in rat and opossum kidney cells are in agreement with the observation that rat renal proximal tubules and opossum kidney cells express mainly the NHE3 isoform. The D1-like receptor agonist SKF 38393 inhibited NHE3 activity in a concentration-dependent manner in both rat and opossum cells. The D1-mediated inhibition of NHE3 was prevented either by the D1-like receptor antagonist SKF 83566 (1 microM), overnight treatment with cholera toxin (500 ng/ml) and the PKA antagonist H-89 (10 microM) in rat and opossum kidney cells. The effect of SKF 38393 was abolished by the PKC antagonist chelerythrine (1 microM), or the PLC inhibitor U-73,122 (3 microM) in opossum cells, but not in rat cells. In addition, dibutyril cAMP (dB-cAMP; 500 microM) was found to increase PLC activity in OK cells but not in rat cells. The effect of D1-like dopamine agonist was accompanied by increases in cyclic AMP production in rat and opossum cells. The inhibitory effect of SKF 38393 (1 microM) on NHE3 activity was abolished in rat and opossum cells pre-treated with the anti-GSalpha antibody, but not in cells treated with the anti-Gq/11 alpha antibody. It is concluded that D1 agonists decrease NHE3 activity by classical stimulation of AC and PKA via GSalpha proteins in rat kidney cells. By contrast, the D1-mediated inhibition of NHE3 in renal opossum cells involves a peculiar mechanism with AC-PKA and PLC-PKC pathways.
多巴胺D1样受体通过G蛋白与多种细胞信号通路相连,即腺苷酸环化酶(AC)和磷脂酶C(PLC)。我们之前已经表明,D1介导的OK细胞中Na+-K+-ATP酶活性的抑制涉及AC-蛋白激酶A(AC-PKA)和PLC-蛋白激酶C(PLC-PKC)信号通路的顺序激活。本研究评估了大鼠和负鼠肾细胞中多巴胺介导的Na+/H+交换体亚型3(NHE3)抑制所涉及的信号级联反应。Na+/H+交换体活性通过酸负荷后细胞内pH(pHi)恢复的初始速率来测定。大鼠细胞中Na+依赖性pHi恢复的Vmax值(以pH单位/秒计)(0.0097±0.0007)高于(P<0.05)负鼠细胞中的(0.0063±0.0007),而Na+的Km值(以mM计)相似(大鼠,35±9;负鼠,24±9)。EIPA和阿米洛利诱导大鼠和负鼠肾细胞中NHE活性降低的IC50值与大鼠肾近端小管和负鼠肾细胞主要表达NHE3亚型的观察结果一致。D1样受体激动剂SKF 38393在大鼠和负鼠细胞中均以浓度依赖性方式抑制NHE3活性。在大鼠和负鼠肾细胞中,D1样受体拮抗剂SKF 83566(1μM)、霍乱毒素(500 ng/ml)过夜处理以及PKA拮抗剂H-89(10μM)均可阻止D1介导的NHE3抑制。在负鼠细胞中,PKC拮抗剂白屈菜红碱(1μM)或PLC抑制剂U-73122(3μM)可消除SKF 38393的作用,但在大鼠细胞中则不然。此外,发现二丁酰cAMP(dB-cAMP;500μM)可增加OK细胞中的PLC活性,但在大鼠细胞中则不然。D1样多巴胺激动剂的作用伴随着大鼠和负鼠细胞中环状AMP生成的增加。在用抗GSα抗体预处理的大鼠和负鼠细胞中,SKF 38393(1μM)对NHE3活性的抑制作用被消除,但在用抗Gq/11α抗体处理的细胞中则未被消除。结论是,D1激动剂通过经由GSα蛋白对AC和PKA的经典刺激降低大鼠肾细胞中NHE3的活性。相比之下,D1介导的负鼠肾细胞中NHE3的抑制涉及AC-PKA和PLC-PKC信号通路的特殊机制。